Strategy
MSTR
MARA Holdings
MARA
Tesla
TSLA
Coinbase
COIN
Apple
AAPL
US Stock MarketDetailed Quotes
PFE Pfizer
- 26.430
- +0.330+1.26%
Close Feb 28 16:00 ET
- 26.350
- -0.080-0.30%
Post 19:59 ET
149.79BMarket Cap18.74P/E (TTM)
26.490High25.910Low51.53MVolume26.055Open26.100Pre Close1.35BTurnover0.91%Turnover Ratio18.74P/E (Static)5.67BShares30.55252wk High1.70P/B149.56BFloat Cap23.71352wk Low1.68Dividend TTM5.66BShs Float53.002Historical High6.36%Div YieldTTM2.22%Amplitude5.306Historical Low26.272Avg Price1Lot Size
About Pfizer Company
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.
Company Profile
SymbolPFE
Company NamePfizer
Listing DateJan 17, 1944
Founded1849
CEODr. Albert Bourla, D.V.M.,PhD
MarketNYSE
Employees81000
Fiscal Year Ends12-31
Address66 Hudson Boulevard East
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10001-2192
Phone1-212-733-2323
Websitehttp://www.pfizer.com
Company Executives
- Name
- Position
- Salary
- Dr. Albert Bourla, D.V.M.,PhD
- Chairman of the Board and Chief Executive Officer
- 21.56M
- Payal Sahni
- Chief People Experience Officer and Executive Vice President
- --
- Aamir Malik
- Chief U.S. Commercial Officer and Executive Vice President
- 5.42M
- Alexandre de Germay
- Chief International Commercial Officer and Executive Vice President
- --
- Michael McDermott
- Executive Vice President, Chief Global Supply and Quality Officer
- --
- Douglas M. Lankler
- Chief Legal Officer and Executive Vice President
- 5.48M
- David M. Denton
- Chief Financial Officer and Executive Vice President
- 5.28M
- Lidia L. Fonseca
- Executive Vice President, Chief Digital and Technology Officer
- --
- Dr. Chris Boshoff, M.D.,PhD
- Chief Scientific Officer and President, Research and Development
- --
- Dr. Andrew Baum, M.D.
- Executive Vice President, Chief Strategy and Innovation Officer
- --
- Sally Susman
- Chief Corporate Affairs Officer and Executive Vice President
- --
- Jennifer B. Damico
- Principal Accounting Officer, Senior Vice President and Controller
- --
- Margaret M. Madden
- Senior Vice President, Corporate Secretary and Chief Governance Counsel
- --
- Mortimer J. Buckley
- Director
- --
- Cyrus Taraporevala
- Director
- --
- Dr. Susan J. Hockfield, PhD
- Independent Director
- 363.00K
- Suzanne Nora Johnson
- Independent Director
- 410.00K
- James Robert Quincey
- Independent Director
- 380.00K
- James C. Smith
- Independent Director
- 390.00K
- Ronald E. Blaylock
- Independent Director
- 380.00K
- Dr. Helen H. Hobbs, M.D.
- Independent Director
- 410.00K
- Dr. Scott Gottlieb,M.D.
- Independent Director
- 417.20K
- Shantanu Narayen
- Lead Independent Director
- 430.00K
- Joseph J. Echevarria
- Independent Director
- 390.00K
- Dr. Dan R. Littman, M.D.,PhD
- Independent Director
- 391.40K
- Dr. Susan D. Desmond-Hellmann, M.D.,M.P.H.
- Independent Director
- 360.00K
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
